← Leaderboards
Daniel G Anderson
Massachusetts Institute Of Technology
$11,913,058
Attributed
$19,322,488
Total exposure
11
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,322,488 · 11
By mechanism
R01$7,939,673 · 4
UH3$2,938,558 · 1
UG3$2,700,237 · 1
R61$2,144,122 · 1
RC1$1,975,066 · 2
R33$1,497,172 · 1
Top collaborators
- Guang-Ping Gao6 shared
- Klavs F Jensen6 shared
- Wen Xue6 shared
- Kwang-Soo Kim4 shared
- Matthias Nahrendorf4 shared
- Robert S Langer3 shared
- Clark K Colton1 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Robert S Langer$47,407,448
- Klavs F Jensen$1,018,304
- Gareth H McKinley$943,838
- Irmgard Bischofberger$566,713
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsDesignIn VivoProductionGenerationsTechnologyProteinsNanoparticle DeliveryToxic EffectViralStem CellsAnimal ModelMutationGenesDoseStructureMessenger RnaModificationFutureMouse ModelPropertyBiologicalCombinatorialImmune
Grant awards (33)
Combinatorial and computational design of bnAb mRNA vaccines for HIV$771,167
R33 · FY2025 · AI · contact PI
SMART BIOELECTRONIC IMPLANTS FOR CONTROLLED DELIVERY OF THERAPEUTIC PROTEINS IN VIVO AND ITS APPLICATION IN LONG-TERM TREATMENT OF HEMOPHILIA A$604,673
R01 · FY2025 · EB · contact PI
Nonviral delivery techniques for in vivo prime editing$387,750
R01 · FY2025 · HL · contact PI
Combinatorial and computational design of bnAb mRNA vaccines for HIV$726,005
R33 · FY2024 · AI · contact PI
SMART BIOELECTRONIC IMPLANTS FOR CONTROLLED DELIVERY OF THERAPEUTIC PROTEINS IN VIVO AND ITS APPLICATION IN LONG-TERM TREATMENT OF HEMOPHILIA A$592,580
R01 · FY2024 · EB · contact PI
Nonviral delivery techniques for in vivo prime editing$387,750
R01 · FY2024 · HL · contact PI
Combinatorial and computational design of bnAb mRNA vaccines for HIV$785,418
R61 · FY2023 · AI · contact PI
SMART BIOELECTRONIC IMPLANTS FOR CONTROLLED DELIVERY OF THERAPEUTIC PROTEINS IN VIVO AND ITS APPLICATION IN LONG-TERM TREATMENT OF HEMOPHILIA A$604,673
R01 · FY2023 · EB · contact PI
Nonviral delivery techniques for in vivo prime editing$387,750
R01 · FY2023 · HL · contact PI
Develop combinatorial non-viral and viral CRISPR delivery for lung diseases$1,660,678
UH3 · FY2022 · HL
Combinatorial and computational design of bnAb mRNA vaccines for HIV$789,957
R61 · FY2022 · AI · contact PI
SMART BIOELECTRONIC IMPLANTS FOR CONTROLLED DELIVERY OF THERAPEUTIC PROTEINS IN VIVO AND ITS APPLICATION IN LONG-TERM TREATMENT OF HEMOPHILIA A$604,673
R01 · FY2022 · EB · contact PI
Nonviral delivery techniques for in vivo prime editing$387,750
R01 · FY2022 · HL · contact PI
Develop combinatorial non-viral and viral CRISPR delivery for lung diseases$1,277,880
UH3 · FY2021 · HL
Combinatorial and computational design of bnAb mRNA vaccines for HIV$568,747
R61 · FY2021 · AI · contact PI
Develop combinatorial non-viral and viral CRISPR delivery for lung diseases$795,706
UG3 · FY2020 · HL
Interfering with the macrophage life cycle of atherosclerosis$477,352
R01 · FY2020 · HL
Develop combinatorial non-viral and viral CRISPR delivery for lung diseases$802,570
UG3 · FY2019 · HL
Interfering with the macrophage life cycle of atherosclerosis$477,352
R01 · FY2019 · HL
Develop combinatorial non-viral and viral CRISPR delivery for lung diseases$275,792
UG3 · FY2019 · HL
Develop combinatorial non-viral and viral CRISPR delivery for lung diseases$826,169
UG3 · FY2018 · HL
Interfering with the macrophage life cycle of atherosclerosis$477,352
R01 · FY2018 · HL
Interfering with the macrophage life cycle of atherosclerosis$495,102
R01 · FY2017 · HL
High throughput microfluidic intracellular delivery platform$510,860
R01 · FY2016 · GM
High throughput microfluidic intracellular delivery platform$510,860
R01 · FY2015 · GM
High throughput microfluidic intracellular delivery platform$510,860
R01 · FY2014 · GM
High throughput microfluidic intracellular delivery platform$522,336
R01 · FY2013 · GM
Human Pluripotent Stem Cell Differentiation with Defined O2 & Protein Engagement$975,069
RC1 · FY2010 · DE
High throughput cell reprogramming by microfluidic jet injection$499,998
RC1 · FY2010 · EB
High throughput cell reprogramming by microfluidic jet injection$499,999
RC1 · FY2009 · EB
BIOENGINEERING OF PROTEIN BASED GENE DELIVERY AGENTS$48,148
F32 · FY2002 · CA
BIOENGINEERING OF PROTEIN BASED GENE DELIVERY AGENTS$41,996
F32 · FY2001 · CA
BIOENGINEERING OF PROTEIN BASED GENE DELIVERY AGENTS$37,516
F32 · FY2000 · CA